1 Answers
Dr. Shoyeb
এমবিবিএস
,
পিজিটি(মেডিসিন)
,
সিসিডি(বারডেম)
,
সিএমইউ
Palbociclib is a kinase inhibitor indicated for the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with:
- An aromatase inhibitor as initial endocrine based therapy in postmenopausal women; or
- Fulvestrant in women with disease progression following endocrine therapy.
Palbocent Capsule সম্পর্কে বিস্তারিত জেনে নিন এই লিঙ্ক থেকে Palbocent
3348 views
Answered